Quick answers
- Is CVE-2026-8310 exploited in the wild?
- No. Junglewise Threat Intelligence has no report of CVE-2026-8310 being exploited in the wild.
- How severe is CVE-2026-8310?
- Medium severity, with a CVSS score of 6.1, published 8 July 2026.
- Which products and versions are affected?
- Webbeyaz Web Design Mediküm Web through 08072026.
- Is there a fix for CVE-2026-8310?
- No fixed version is recorded yet. Check the vendor's advisory in the references below. If you run it, Junglewise drafts a mitigation that fits your setup and applies it once you approve, with senior security engineers behind it.
- How is CVE-2026-8310 attacked?
- It is attacked over the network, in a web application.
- Am I affected by CVE-2026-8310?
- Check whether you run Webbeyaz Web Design Mediküm Web at an affected version. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.
Technical details
A Reflected Cross-Site Scripting (XSS) vulnerability exists in Webbeyaz Web Design Mediküm Web through version 08072026. The flaw stems from the application's failure to properly sanitize user-supplied input before including it in dynamically generated web pages (CWE-79). An unauthenticated remote attacker can exploit this by tricking a user into visiting a malicious URL containing a crafted payload. Successful exploitation allows the execution of arbitrary JavaScript in the context of the victim's browser session. The vendor has confirmed the product is end-of-life (EOL) and no patch is expected.
Affected products
- Webbeyaz Web Design Mediküm Web through 08072026
Timeline
- 2026-07-08: advisory: Initial disclosure by TR-CERT and NVD
- 2026-07-08: other: Vendor confirmed product is no longer supported